Focal Segmental Glomerulosclerosis Treatment Market Set for Expansion from US$ 2.39 Billion in 2025 to 2034
Focal Segmental Glomerulosclerosis Treatment Market demand is also influenced by growing research into genetic factors associated with kidney disorders. Genetic testing can help identify inherited forms of FSGS and support more individualized disease assessment, encouraging investment in molecular diagnostics and precision nephrology.
The focal segmental glomerulosclerosis (FSGS) treatment...
0 Comments
0 Shares